← All peptides
Longevity & Anti-aging
Preclinical

Epitalon

Also known as: Epitalon, Epithalon, Epithalamin

A synthetic tetrapeptide (Ala-Glu-Asp-Gly) based on the pineal peptide epithalamin, studied for telomerase activation, circadian regulation, and longevity in animal and limited human research.

Last updated

Mechanism of Action

Epitalon is a synthetic tetrapeptide modeled on the pineal-gland peptide epithalamin that has been reported to activate telomerase, the enzyme that maintains telomere length. Preclinical work suggests it normalizes melatonin and circadian rhythm, modulates the hypothalamic-pituitary axis, and exerts antioxidant effects. Russian studies report effects on lifespan and age-related markers, though mechanisms in humans remain incompletely defined.

Half-life
Very short in plasma (minutes)
Administration Routes
subcutaneous, intramuscular
Research Status
Preclinical

Reported Benefits

  • Reported telomerase activation in cell and animal studies
  • May normalize melatonin and circadian rhythm
  • Antioxidant effects in preclinical models
  • Russian studies report effects on lifespan markers
  • May support sleep and pineal function

Potential Side Effects

  • Generally well tolerated in available studies
  • Injection-site irritation
  • Theoretical concern: telomerase activity and cancer
  • Sparse, mostly non-Western clinical data

Common Dosing

Research literature references short cycles of ~5-10 mg per day for 10-20 days, repeated periodically. Educational range only.

The dosing information above is aggregated from research literature and anecdotal community reports for educational purposes only. It is not a recommendation, prescription, or medical advice. Peptides are sold as research chemicals only and are not intended for human use.

Contraindications

  • Active or suspected malignancy (telomerase concern)
  • Pregnancy or breastfeeding
  • Not approved for human use outside research settings
  • Epithalon peptide induces telomerase activity and telomere elongation in human somatic cells

    2003

    View
  • Effect of Epitalon on biomarkers of aging, life span and spontaneous tumor incidence in female Swiss-derived SHR mice

    2003

    View
  • Epitalon increases telomere length in human cell lines through telomerase upregulation or ALT activity

    2025

    View
  • Overview of Epitalon-Highly Bioactive Pineal Tetrapeptide with Promising Properties

    2025

    View

No. Epitalon is not FDA-approved for any use. In July 2026, FDA's Pharmacy Compounding Advisory Committee voted 7-4 (one abstention) to recommend adding it to the 503A bulks list, which would let licensed pharmacies compound it with a prescription for insomnia. FDA's own reviewers had recommended against it. The indication voted on was insomnia, not longevity. The vote is advisory, not an approval: FDA has not acted on it, and adding a substance to the 503A list requires formal rulemaking. As of October 2026 nothing has legally changed.

It is best known for reported telomerase activation and telomere lengthening in cell studies, along with circadian and melatonin-normalizing effects, forming the basis of its longevity research interest.

Most data come from Russian preclinical and small human studies. The findings are intriguing but not confirmed by large, independent Western trials.

PeptideQuestions is for educational and research purposes only. Nothing on this site constitutes medical advice. Peptides are sold as research chemicals only and are not intended for human use. These statements have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease. PeptideQuestions is an independent educational resource — not a pharmacy, compounding, or 503A/503B outsourcing facility — and does not sell products or provide medical advice.